Reed Jobs would rather talk about curing cancer than his last name
Source:
techcrunch
July 11, 2026 · 17:16
When we last sat down with Jobs at TechCrunch Disrupt nearly three years ago, his firm Yosemite was brand new and biotech was still reeling from its post-pandemic crash. Now, the venture outfit has a team of 17; a cluster of blockbuster drugs are all losing patent protection in roughly the same window, creating all kinds of new opportunities; and AI has gone from a curiosity to, in Jobs's words, a huge part of what Yosemite does. "I didn't expect Yosemite to be moving this fast," he said.
The original article opens on the publisher's website.
More from Energy
View topic →US defends Venezuela deal as Chevron prepares to expand operations
financialTimes
Sep 1, 2026 · 13:48
What to Know About Venezuelan Energy Following Trump’s Oil Deal
nytimes
Sep 1, 2026 · 10:18
Two More Oil Tankers Are Attacked in the Strait of Hormuz
nytimes
Sep 1, 2026 · 09:16
AI data center firm SB Energy, which is backed by Softbank, Nvidia and OpenAI, files for IPO
cnbc
Sep 1, 2026 · 08:43
Your files stay put: Perplexity’s hybrid AI keeps confidential data off the cloud
ventureBeat
Sep 1, 2026 · 08:00